Fortrea Holdings Inc. (FTRE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $10.80
• Market Cap: $955.42M
• EPS: $-11.35
• 52-Week High: $18.67
• 52-Week Low: $3.97

About Fortrea Holdings Inc.

Fortrea Holdings Inc. is a prominent provider of integrated clinical development and patient access solutions for the life sciences industry, headquartered in Durham, North Carolina. The company utilizes cutting-edge methodologies and technologies to streamline clinical trials, optimize patient engagement, and deliver high-quality support throughout the drug development process. Fortrea's relentless focus on innovation and its deep expertise in navigating regulatory and market challenges make...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fortrea Holdings Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FTRE pay dividends?

Fortrea Holdings Inc. (FTRE) does not currently pay a regular dividend.

What is FTRE's market cap?

Fortrea Holdings Inc. (FTRE) has a market capitalization of $955.42M with a current stock price of $10.80.